⌘K

Home/Filings/4/0001562135-25-000006

4//SEC Filing

EAGLE CRAIG 4

Accession 0001562135-25-000006

CIK 0001576280other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 8:04 PM ET

Size

16.0 KB

Accession

0001562135-25-000006

Insider Transaction Report

Form 4

Period: 2025-10-01

Guardant Health, Inc.GH

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2025-10-01+10,477→ 51,341 total
Exercise/Conversion
Restricted Stock Units
2025-10-01−10,477→ 21,274 total
Exercise: $0.00→ Common Stock (10,477 underlying)
Exercise/Conversion
Common Stock
2025-10-01+1,714→ 39,196 total
Exercise/Conversion
Restricted Stock Units
2025-10-01−1,668→ 6,669 total
Exercise: $0.00→ Common Stock (1,668 underlying)
Exercise/Conversion
Common Stock
2025-10-01+1,668→ 40,864 total
Tax Payment
Common Stock
2025-10-01$62.65/sh−7,025$440,116→ 44,316 total
Exercise/Conversion
Restricted Stock Units
2025-10-01−1,714→ 6,857 total
Exercise: $0.00→ Common Stock (1,714 underlying)

Footnotes (5)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
[F3]Not applicable for Restricted Stock Units.
[F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
[F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Documents

1 file

4
wk-form4_1759449889.xmlPrimary
FORM 4

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1

filerCIK 0001562135

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 8:04 PM ET
Size: 16.0 KB

View on SEC.gov